178 related articles for article (PubMed ID: 33206504)
1. Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation via Distinct Structural Degrons.
Matyskiela ME; Zhu J; Baughman JM; Clayton T; Slade M; Wong HK; Danga K; Zheng X; Labow M; LeBrun L; Lu G; Chamberlain PP; Thompson JW
ACS Chem Biol; 2020 Dec; 15(12):3149-3158. PubMed ID: 33206504
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia promotes degradation of the acute promyelocytic leukemia driver oncoprotein ZBTB16/RARα.
Wang QQ; Hussain L; Yu PH; Yang C; Zhu CY; Ma YF; Wang SC; Yang T; Kang YY; Yu WJ; Maimaitiyiming Y; Naranmandura H
Acta Pharmacol Sin; 2023 Apr; 44(4):822-831. PubMed ID: 36216898
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide and its metabolite 5-hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF.
Yamanaka S; Murai H; Saito D; Abe G; Tokunaga E; Iwasaki T; Takahashi H; Takeda H; Suzuki T; Shibata N; Tamura K; Sawasaki T
EMBO J; 2021 Feb; 40(4):e105375. PubMed ID: 33470442
[TBL] [Abstract][Full Text] [Related]
4. CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells.
Surka C; Jin L; Mbong N; Lu CC; Jang IS; Rychak E; Mendy D; Clayton T; Tindall E; Hsu C; Fontanillo C; Tran E; Contreras A; Ng SWK; Matyskiela M; Wang K; Chamberlain P; Cathers B; Carmichael J; Hansen J; Wang JCY; Minden MD; Fan J; Pierce DW; Pourdehnad M; Rolfe M; Lopez-Girona A; Dick JE; Lu G
Blood; 2021 Feb; 137(5):661-677. PubMed ID: 33197925
[TBL] [Abstract][Full Text] [Related]
5. PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates.
Shimizu N; Asatsuma-Okumura T; Yamamoto J; Yamaguchi Y; Handa H; Ito T
Commun Biol; 2021 Nov; 4(1):1277. PubMed ID: 34764413
[TBL] [Abstract][Full Text] [Related]
6. Profiling CELMoD-Mediated Degradation of Cereblon Neosubstrates.
Thompson JW; Clayton T; Khambatta G; Bateman LA; Carroll CW; Chamberlain PP; Matyskiela ME
Methods Mol Biol; 2021; 2365():283-300. PubMed ID: 34432250
[TBL] [Abstract][Full Text] [Related]
7. Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA.
Li H; Xiang X; Ding H; Yu J; Xu J; Yuan Y; Wu Y
Br J Haematol; 2022 Dec; 199(5):768-771. PubMed ID: 36169236
[No Abstract] [Full Text] [Related]
8. Differential regulation of PML-RARα stability by the ubiquitin ligases SIAH1/SIAH2 and TRIAD1.
Pietschmann K; Buchwald M; Müller S; Knauer SK; Kögl M; Heinzel T; Krämer OH
Int J Biochem Cell Biol; 2012 Jan; 44(1):132-8. PubMed ID: 22037423
[TBL] [Abstract][Full Text] [Related]
9. A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.
Matyskiela ME; Lu G; Ito T; Pagarigan B; Lu CC; Miller K; Fang W; Wang NY; Nguyen D; Houston J; Carmel G; Tran T; Riley M; Nosaka L; Lander GC; Gaidarova S; Xu S; Ruchelman AL; Handa H; Carmichael J; Daniel TO; Cathers BE; Lopez-Girona A; Chamberlain PP
Nature; 2016 Jul; 535(7611):252-7. PubMed ID: 27338790
[TBL] [Abstract][Full Text] [Related]
10. Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA.
Morimoto S; Kondo T; Taya T; Matsuo H; Teramoto Y; Mizumoto C; Kanda J; Yamashita K; Takaori-Kondo A
Ann Hematol; 2022 May; 101(5):1129-1132. PubMed ID: 35347397
[No Abstract] [Full Text] [Related]
11. PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.
Moog-Lutz C; Peterson EJ; Lutz PG; Eliason S; Cavé-Riant F; Singer A; Di Gioia Y; Dmowski S; Kamens J; Cayre YE; Koretzky G
J Biol Chem; 2001 Jun; 276(25):22375-81. PubMed ID: 11301322
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance.
Hussain L; Maimaitiyiming Y; Islam K; Naranmandura H
Semin Oncol; 2019 Apr; 46(2):133-144. PubMed ID: 31126665
[TBL] [Abstract][Full Text] [Related]
13. PML-RARα stabilized by zinc in human acute promyelocytic leukemia NB4 cells.
Zhu B; Wang JY; Zhou JJ; Zhou F; Cheng W; Liu YT; Wang J; Chen X; Chen DH; Luo L; Hua ZC
J Inorg Biochem; 2017 Oct; 175():92-100. PubMed ID: 28743050
[TBL] [Abstract][Full Text] [Related]
14. Variant
Dowse RT; Ireland RM
Blood; 2017 Apr; 129(14):2038. PubMed ID: 28385775
[No Abstract] [Full Text] [Related]
15. Round Promyelocyte Cells with Round Nuclei: Clues to the Diagnosis of
Su Y; Zhao J; Fan X; Yang W; Liu J
Turk J Haematol; 2023 Dec; 40(4):273-274. PubMed ID: 37314303
[No Abstract] [Full Text] [Related]
16. A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.
Matyskiela ME; Zhang W; Man HW; Muller G; Khambatta G; Baculi F; Hickman M; LeBrun L; Pagarigan B; Carmel G; Lu CC; Lu G; Riley M; Satoh Y; Schafer P; Daniel TO; Carmichael J; Cathers BE; Chamberlain PP
J Med Chem; 2018 Jan; 61(2):535-542. PubMed ID: 28425720
[TBL] [Abstract][Full Text] [Related]
17. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
18. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera.
Kim K; Lee DH; Park S; Jo SH; Ku B; Park SG; Park BC; Jeon YU; Ahn S; Kang CH; Hwang D; Chae S; Ha JD; Kim S; Hwang JY; Kim JH
Sci Rep; 2019 Dec; 9(1):19654. PubMed ID: 31873151
[TBL] [Abstract][Full Text] [Related]
19. CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia.
Hansen JD; Correa M; Alexander M; Nagy M; Huang D; Sapienza J; Lu G; LeBrun LA; Cathers BE; Zhang W; Tang Y; Ammirante M; Narla RK; Piccotti JR; Pourdehnad M; Lopez-Girona A
J Med Chem; 2021 Feb; 64(4):1835-1843. PubMed ID: 33591756
[TBL] [Abstract][Full Text] [Related]
20. A case of acute promyelocytic leukaemia with unusual cytological features and a ZBTB16-RARA fusion gene.
Lechevalier N; Dulucq S; Bidet A
Br J Haematol; 2016 Aug; 174(4):502. PubMed ID: 27302179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
